| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0003015> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0008115> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0011849> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0011881> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0021515> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0024683> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0026538> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0033105> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0035096> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0035237> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0037186> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0086907> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0282335> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0521942> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0815017> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C0960880> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C3178990> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C4759705> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C4759706> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C5392966> <https://research.tib.eu/covid-19/entity/32561317_HAS_TOPIC_C5392967>
?:authorAffiliation	[]
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Jaberi-Douraki_Majid> <https://research.tib.eu/covid-19/entity/Kawakami_Jessica> <https://research.tib.eu/covid-19/entity/Riviere_Jim_E> <https://research.tib.eu/covid-19/entity/Stafford_Emma_G> <https://research.tib.eu/covid-19/entity/Wyckoff_Gerald_J> <https://research.tib.eu/covid-19/entity/Xu_Xuan>
?:doi	S1544-3191(20)30261-210.1016/j.japh.2020.05.018
?:doi	<https://research.tib.eu/covid-19/entity/S1544-3191%2820%2930261-210.1016/j.japh.2020.05.018>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Journal of the American Pharmacists Association : JAPhA
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32561317>
?:pmid	<https://research.tib.eu/covid-19/entity/32561317>
?:pmid	32561317
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.4
?:rankingScore_hIndex	57
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0006938_AFFECTS_C0001314> <https://research.tib.eu/covid-19/entity/C0006938_AFFECTS_C3714514> <https://research.tib.eu/covid-19/entity/C0011847_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C0013227_AFFECTS_C0221423>
?:title	Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32561317>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32561317>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all